Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Polydex updates progress of Ushercell

Oct. 11, 2002

Novel hypolipidemic agents with multiple mechanisms of action described by Takeda

Oct. 10, 2002

Wakunaga presents new inhibitors of MTP for lipid disorders

Oct. 10, 2002

Wyeth selects compound in women's healthcare for development pipeline

Oct. 10, 2002

GSK researchers design thiazoles for PPAR-mediated diseases

Oct. 9, 2002

ICA-17043 receives fast track status in sickle cell anemia

Oct. 9, 2002

Efficacy and safety of KUR-1246 as a new tocolytic agent further explored

Oct. 9, 2002

Greater reduction in bone resorption reported for alendronate vs. risedronate in osteoporosis

Oct. 9, 2002

Modulators of PPARgamma receptors and their use in obesity, diabetes and lipid disorders

Oct. 9, 2002

PPAR agonists in the development pipeline at Merck

Oct. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...